Form 4: POCI Director Buell Granted 30,000 Stock Options

Precision Optics Corporation director Duncan Buell received a grant of 30,000 stock options with an exercise price of $4.33, vesting over four installments through September 2026.

Summary

• Duncan Buell, a Director of Precision Optics Corporation, Inc. (POCI), was granted 30,000 stock options.
• The transaction date for this acquisition of derivative securities was November 17, 2025.
• The exercise price for these stock options is $4.33 per share.
• The options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026.
• Vesting is contingent upon Mr. Buell's continuous employment with the Issuer through each applicable vesting date.
• The options were granted under the Precision Optics Corporation, Inc. 2022 Equity Incentive Plan.
• The expiration date for these options is November 17, 2035.
• Following this transaction, Mr. Buell beneficially owns 30,000 derivative securities directly.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as it reflects standard compensation practices that align director interests with shareholders, without indicating any immediate negative operational or financial news.

Positives

• The grant of stock options aligns the director's financial interests with those of the shareholders, incentivizing long-term company performance.
• The options were granted under an established equity incentive plan (Precision Optics Corporation, Inc. 2022 Equity Incentive Plan), indicating a structured approach to executive compensation.

Risks

• The vesting of the stock options is subject to the reporting person remaining in continuous employment of the Issuer through the applicable vesting dates, posing a risk of forfeiture if employment ceases.

Future Outlook

The vesting schedule for the granted stock options extends through September 2026, indicating an expectation of continued service from the director during this period.

Industry Context

The grant of stock options to a director is a common practice in publicly traded companies, serving as a form of long-term incentive compensation to align management and director interests with shareholder value creation. This is a standard mechanism within corporate governance frameworks.

Comparison to Industry Standards

• Granting stock options as part of director compensation is a widely accepted practice across various industries, including the optics and technology sectors where Precision Optics Corporation operates.
• The vesting schedule over multiple years is typical for equity incentive plans, designed to encourage long-term commitment and performance, comparable to practices at companies like Lumentum Holdings Inc. or Coherent Corp. in the optical components space.

Stakeholder Impact

• Shareholders: The grant of options aims to align the director's interests with shareholder value creation, potentially leading to better long-term performance.
• Employees: The continuous employment condition for vesting reinforces the importance of key personnel retention.

Next Steps

• The stock options will vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, subject to continuous employment.

Key Dates

Keywords

POCI, Precision Optics Corporation, stock options, Form 4, insider transaction, equity incentive plan, director compensation, beneficial ownership